Pharmacology Books
Pharmaceutical Press British National Formulary BNF 91 March 2026
a huge range and FREE tracked UK delivery on ALL orders.
£74.70
Mdpi AG Advances in Minimally Invasive Liver Resection
Book Synopsis
£44.63
Little, Brown Book Group Bartram's Encyclopedia of Herbal Medicine
Book SynopsisContaining over 900 entries of general disease conditions and corresponding herbal treatments, this book covers: therapeutic action, 550 monographs of medicinal plants, and the properties of herbs and preparations such as inctures, liquid extracts, poultices and essential oils.
£14.24
World Scientific Publishing Co Pte Ltd Cobert's Manual Of Drug Safety And
Book SynopsisCompletely revised and updated, Cobert's Manual of Drug Safety and Pharmacovigilance, Third Edition, is a how-to manual for those working in the fields of drug safety, clinical research, pharmacology, regulatory affairs, risk management, quality/compliance, and in government and legal professions.This comprehensive and practical guide discusses the theory and the practicalities of drug safety (also known as pharmacovigilance), and provides essential information on drug safety and regulations in the United States, Europe Union, and more, including: recognizing, monitoring, reporting, and cataloging serious adverse drug reactions.Cobert's Manual of Drug Safety and Pharmacovigilance, Third Edition, teaches the daily practice of drug safety in industry, hospitals, the FDA and other health agencies — both in the United States and around the world — and provides critical information about what to do when confronted with a drug safety problem.Related Link(s)
£52.25
Elsevier - Health Sciences Division Rang Dales Pharmacology
Book SynopsisTable of ContentsSECTION 1 GENERAL PRINCIPLES 1. What is pharmacology? 2. How drugs act: general principles 3. How drugs act: molecular aspects 4. How drugs act: cellular aspects - excitation, contraction and secretion 5. How drugs act: Biopharmaceuticals and gene therapy 6. Cell proliferation, apoptosis, repair and regeneration 7. Cellular mechanisms: host defence 8. Method and measurement in pharmacology 9. Absorption and distribution of drugs 10. Drug metabolism and elimination 11. Pharmacokinetics 12. Individual variation, pharmacogenomics and personalised medicine SECTION 2 CHEMICAL MEDIATORS 13. Chemical mediators and the autonomic nervous system 14. Cholinergic transmission 15. Noradrenergic transmission 16. 5-Hydroxytryptamine and purines 17. Local hormones: histamine, lipids, peptides and proteins 18. Cannabinoids 19. Nitric oxide and related mediators SECTION 3 DRUGS AFFECTING MAJOR ORGAN SYSTEMS 20. The heart 21. The vascular system 22. Atherosclerosis and lipoprotein metabolism 23. Haemostasis and thrombosis 24. Haemopoietic system and treatment of anaemia 25. Anti-inflammatory and immunosuppressant drugs 26. Skin 27. Eye 28. Respiratory system 29. The kidney and urinary system 30. The gastrointestinal tract 31. The control of blood glucose and drug treatment of diabetes mellitus 32. Obesity 33. The pituitary and the adrenal cortex 34. Thyroid 35. The reproductive system 36. Bone metabolism SECTION 4 NERVOUS SYSTEM 37. Chemical transmission and drug action in the central nervous system 38. Amino acid transmitters 39. Other transmitters and modulators 40. Neurodegenerative diseases 41. General anaesthetic agents 42. Headache 43. Analgesic drugs 44. Local anaesthetics and other drugs affecting sodium channels 45. Anxiolytic and hypnotic drugs 46. Antiepileptic drugs 47. Antipsychotic drugs 48. Antidepressant drugs 49. Psychoactive drugs 50. Drug use and addiction SECTION 5 DRUGS USED FOR THE TREATMENT OF INFECTIONS AND CANCER 51. Basic principles of antimicrobial chemotherapy 52. Antibacterial drugs 53. Antiviral drugs 54. Antifungal drugs 55. Antiprotozoal drugs 56. Antihelminthic drugs 57. Anticancer drugs SECTION 6 SPECIAL TOPICS 58. Harmful effects of drugs 59. Lifestyle drugs and drugs in sport 60. Drug discovery and development Index
£54.14
Elsevier - Health Sciences Division The Top 100 Drugs
Book SynopsisTable of ContentsList of abbreviations Introduction The top 100 drugs listed by system The top 100 drugs listed by indication The top 100 drugs (alphabetical listing) 5a-reductase inhibitors a-blockers Acetylcholinesterase inhibitors Acetylcysteine (N-acetylcysteine) Activated charcoal Adenosine Adrenaline (epinephrine) Aldosterone antagonists Alginates and antacids Allopurinol Aminoglycosides Aminosalicylates Amiodarone Angiotensin-converting enzyme (ACE) inhibitors Angiotensin receptor blockers Antidepressants, selective serotonin reuptake inhibitors Antidepressants, tricyclics and related drugs Antidepressants, venlafaxine and mirtazapine Antiemetics, dopamine D2-receptor antagonists Antiemetics, histamine H1-receptor antagonists Antiemetics, serotonin 5-HT3-receptor antagonists Antifungal drugs Antihistamines (H1-receptor antagonists) Antimotility drugs Antimuscarinics, bronchodilators Antimuscarinics, cardiovascular and gastrointestinal uses Antimuscarinics, genitourinary uses Antipsychotics, first-generation (typical) Antipsychotics, second-generation (atypical) Antiviral drugs Antiplatelet drugs, ADP-receptor antagonists Antiplatelet drugs, aspirin Azathioprine ß-blockers ß2-agonists Benzodiazepines Bisphosphonates Calcium and vitamin D Calcium channel blockers Carbamazepine Cephalosporins and carbapenems Chloramphenicol Corticosteroids (glucocorticoids), inhaled Corticosteroids (glucocorticoids), systemic Corticosteroids (glucocorticoids), topical Digoxin Dipeptidylpeptidase-4 inhibitors Direct oral anticoagulants Diuretics, loop Diuretics, thiazide and thiazide-like Dopaminergic drugs for Parkinson's disease Emollients Fibrinolytic drugs Gabapentin and pregabalin H2-receptor antagonists Heparins and fondaparinux Insulin Iron Lamotrigine Laxatives, osmotic Laxatives, stimulant Leukotriene receptor antagonists Levetiracetam Lidocaine Macrolides Metformin Methotrexate Metronidazole Naloxone Nicotine replacement and related drugs Nitrates Nitrofurantoin Non-steroidal antiinflammatory drugs Ocular lubricants (artificial tears) Oestrogens and progestogens Opioids, strong Opioids, weak/moderate Oxygen Paracetamol Penicillins Penicillins, antipseudomonal Penicillins, broad-spectrum Penicillins, penicillinase-resistant Phosphodiesterase (type 5) inhibitors Prostaglandin analogue eye drops Proton pump inhibitors Quinine Quinolones Serotonin 5-HT1-receptor agonists Sex hormone antagonists for breast cancer Statins Sulphonylureas Tetracyclines Thyroid hormones Trimethoprim Valproate (valproic acid) Vancomycin Vitamins Warfarin Z-drugs Fluids Colloids (plasma substitutes) Compound sodium lactate (Hartmann's solution) Glucose (dextrose) Potassium chloride Sodium chloride Self-assessment and knowledge integration 100 single best-answer questions Answers and explanations Index
£18.04
Pharmaceutical Press Palliative Care Formulary
Book SynopsisThe eighth edition of the Palliative Care Formulary (PCF), from Pharmaceutical Press, the Royal Pharmaceutical Society's knowledgebusiness, is an essential resource for health professionals who care for patients with progressive end-stage disease.
£59.36
Chelsea Green Publishing Co The Lost Language of Plants: The Ecological
Book SynopsisThis could be the most important book you will read this year. Around the office at Chelsea Green it is referred to as the "pharmaceutical Silent Spring." Well-known author, teacher, lecturer, and herbalist Stephen Harrod Buhner has produced a book that is certain to generate controversy. It consists of three parts: A critique of technological medicine, and especially the dangers to the environment posed by pharmaceuticals and other synthetic substances that people use in connection with health care and personal body care. A new look at Gaia Theory, including an explanation that plants are the original chemistries of Gaia and those phytochemistries are the fundamental communications network for the Earth's ecosystems. Extensive documentation of how plants communicate their healing qualities to humans and other animals. Western culture has obliterated most people's capacity to perceive these messages, but this book also contains valuable information on how we can restore our faculties of perception. The book will affect readers on rational and emotional planes. It is grounded in both a New Age spiritual sensibility and hard science. While some of the author's claims may strike traditional thinkers as outlandish, Buhner presents his arguments with such authority and documentation that the scientific underpinnings, however unconventional, are completely credible. The overall impact is a powerful, eye-opening expos' of the threat that our allopathic Western medical system, in combination with our unquestioning faith in science and technology, poses to the primary life-support systems of the planet. At a time when we are preoccupied with the terrorist attacks and the possibility of biological warfare, perhaps it is time to listen to the planet. This book is essential reading for anyone concerned about the state of the environment, the state of health care, and our cultural sanity.Table of Contents1. The Taste of Wild Water 2. The Two Wounds 3. Epistemological Conflict 4. The Loss of Biophilia and Biognosis 5. The Environmental Impacts of Technological Medicine 6. The End of Antibiotics 7. "Plants Are All Chemists" 8. Plants as Medicines for All Life on Earth 9. Herbelegy 10. The Lost Language of Plants 11. Living Biognosis: The Work of Carol McGrath, Sparrow, Rosemary Gladstar, John Seed
£15.19
Taylor & Francis Symptoms and Signs of Substance Use
Book SynopsisThis fourth edition of Symptoms and Signs of Substance Use has been thoroughly updated and revised, continuing to provide trusted information from leading experts.There are few countries that are not touched by some aspect of substance misuse and the consequences for individuals, families and the wider community can be devastating. This edition includes new legislation, in relation to cannabis and Novel Psychoactive Substances (NPS), as well as the following features: basic principles of treatment for the most commonly encountered substancesâfrom tobacco and alcohol to cocaine and heroin, as well as 'designer' drugs, the legal aspects of substance use highlighted throughout, a convenient A-Z format helps you find information at a glance, references and further reading direct you to more authoritative information about each substance and review questions at the end of each chapter. With specialist information clearly explained along with a full glossary, this book is essen
£31.34
Hayle Medical Pharmacotherapy: A Pathophysiological Approach
a huge range and FREE tracked UK delivery on ALL orders.
£92.86
North Atlantic Books,U.S. The Book of Herbal Wisdom: Using Plants as
Book Synopsis
£19.55
Elsevier - Health Sciences Division Brodys Human Pharmacology
Book SynopsisTable of ContentsSection 1 Mechanisms of Drug Action and Therapeutic Principles 1. Introduction, Terminology 2. Pharmacodynamics: Drug Targets (Receptors, Enzymes, DNA, etc) 3. Pharmacokinetics 4. Pharmacogenomics 5. Drug Discovery, Development, and Regulation Section 2 Chemical Mediators and Drugs Affecting Autonomic and Neuromuscular Synapses 6. Introduction to the Peripheral Nervous Systems and Drugs for Peripheral Disorders Cholinergic Drugs 7. Muscarinic Agonists and Their Clinical Uses 8. Muscarinic Antagonists and Their Clinical Uses 9. Nicotinic Agonists and Their Clinical Uses 10. Nicotinic Antagonists and Neuromuscular Blocking Drugs Adrenergic Drugs 11. Adrenergic Agonists and Their Clinical Uses 12. Adrenergic Antagonists and Their Clinical Uses Section 3 Drug Treatment for Disorders Affecting the Central Nervous System 13. Introduction to the CNS and Drugs Affecting the Brain Neurodegenerative Disorders 14. Drug Therapy for Alzheimer's Disease and Other Cognitive Disorders/Dementias 15. Pharmacotherapy of Basal Ganglia Disorders: Parkinson's Disease and Huntington's Disease 16. Drug Therapy for Psychoses and Bipolar Disorder 17. Drug Therapy for Depression and Anxiety 18. Drug Therapy for the Management of Attention Deficit Hyperactivity Disorder 19. Drug Therapy for Insomnia and the Hypersomnias 20. Drug Therapy for Managing Obesity and Eating Disorders 21. Treatment of Seizure Disorders 22. Drug Therapy to Control Spasticity Disorders 23. Ethanol, Other Alcohols, and Drugs for Alcohol Use Disorder 24. Illicit Psychoactive Compounds and Substance Use Disorder Section 4 Drug Therapy for Pain Management 25. Introduction 26. General Anesthetics 27. Local Anesthetics 28. Opioid Analgesics 29. Nonsteroidal Anti-inflammatory Agents and Acetaminophen 30. Cannabinoids Section 5 Treatment of Inflammatory, Allergic and Immunologic Disorders 31. Drug Therapy for Migraine Headache 32. Drug Therapy for Gout and Hyperuricemia 33. Drug Treatment for Allergic Reactions 34. Immunosuppressants for Autoimmune Disorders and Organ Transplantation 35. Drug Therapy for Rheumatoid Arthritis Section 6 Drug Treatment for Cardiovascular Diseases 36. Introduction to The Cardiovascular System and the Regulation of Blood Pressure and Heart Rate 37. Overview of Hypertension Management and Drugs that Decrease Sympathetic Tone 38. Diuretics and Drugs that Affect Volume and Electrolyte Content 39. Drugs Affecting the Renin-Angiotensin-Aldosterone System 40. Calcium Channel Blockers 41. Vasodilators 42. Drug Therapy for Hyperlipidemias and Atherosclerotic Cardiovascular Disease 43. Drug Therapy for Myocardial Ischemia and Angina Pectoris 44. Treatment of Heart Failure: Cardiac Glycosides, Phosphodiesterase Inhibitors and Other Agents 45. Antiarrhythmic Drugs 46. Anticoagulant, Antiplatelet and Thrombolytic Agents 47. Drug Therapy for Hemophilia and the Anemias Section 7 Treatment of Endocrine Disorders 48. Introduction to Endocrine Pharmacology 49. Treatment of Hypothalamic and Pituitary Disorders 50. Treatment of Adrenalcorticosteroid Disorders 51. Female Hormone Regulation 52. Androgens, antiandrogens and their clinical uses 53. Drug Therapy for the Management of Diabetes 54. Drug Therapy for the Management of Thyroid Disorders 55. Calcium Regulating Hormones and Agents Affecting Bone Section 8 Chemotherapy Infectious Diseases 56. Principles of Antimicrobial Use 57. Bacterial Cell Wall Synthesis Inhibitors 58. Inhibitors of Protein Synthesis 59. Drugs that Target DNA 60. Antimycobacterial Drugs and the Treatment of Tuberculosis and Leprosy 61. Drug Therapy for Resistant Organisms Parasitic Diseases 62. Antifungal Agents 63. Antimalarial and Other Antiprotozoal Agents 64. Antihelmintics Viruses 65. Drug Therapy for non-HIV Viral Infections 66. Drugs for HIV and Related Opportunistic Infections Cancer 67. Introduction and Therapeutic Principles 68. Cytotoxic Agents 69. Targeted Agents Section 9 Special Considerations 70. Therapeutic Use of Hematopoietic Growth Factors, Vitamins and Minerals 71. Gastrointestinal Disorders and Their Treatment 72. Pharmacological Treatment of Asthma and COPD 73. The Role of Neutraceuticals and Natural Products 74. Essentials of Toxicology 75. Therapeutic Considerations for Pregnant, Pediatric, Geriatric and Obese Individuals
£56.99
Elsevier Health Sciences Pharmaceutical Analysis
Book SynopsisTable of ContentsChapter 1 Control of the quality of analytical methods Chapter 2 Physical and chemical properties of drug molecules Chapter 3 Titrimetric and chemical analysis methods Chapter 4 Ultraviolet and visible spectroscopy Chapter 5 Infrared spectrophotometry Chapter 6 Atomic spectrophotometry Chapter 7 Molecular emission spectroscopy Chapter 8 Nuclear magnetic resonance spectroscopy Chapter 9 Mass spectrometry Chapter 10 Chromatographic theory Chapter 11 Gas chromatography Chapter 12 High-performance liquid chromatography Chapter 13 Thin-layer chromatography Chapter 14 High-performance capillary electrophoresis Chapter 15 Extraction methods in pharmaceutical analysis Chapter 16 Methods used in the quality control of biotechnologically produced drugs Chapter 17 Electrochemical biosensors
£42.74
Lippincott Williams and Wilkins Abrams Clinical Drug Therapy
Book SynopsisWritten by expert pharmacology educators and clinicians, Abrams’ Clinical Drug Therapy has a long tradition of guiding students and instructors through the practice of safe and effective medication administration. Highly praised for its organized and readable presentation, the text explains the 'why' behind each nursing action, and emphasizes individualized nursing care and drug therapy. Filled with vibrant illustrations, including new concept maps, the text provides a solid foundation for understanding clinical drug therapy, evidence-based standards for administration, and how to prevent or minimize adverse effects. Complemented with exciting free online resources, the textbook employs innovative features that guide students through the course, while also preparing for success on the NCLEX® Examination and in nursing practice.Also included is a free copy of Lippincott's Photo Atlas of Medication Administration , which uses the nursing proce
£54.75
Dorling Kindersley Ltd Concise Guide to Medicine Drugs 7th Edition
Book SynopsisThe complete home reference to more than 3000 drugs used to treat most major conditions.From how drugs work to practical advice on the uses, side effects, and risks associated with different prescription medicines and over-the-counter drugs, this medicine book explains it all.Inside the pages of Concise Guide to Medicine & Drugs, you''ll find:- Drugs are organised clearly in an A-Z format, with principal drugs groups arranged by body system or disease group- Text-only section on how major drug groups work on the body- Updated Drug Finder index that lists 3,000 generic and brand-name drugs available in the UKClear, concise and jargon-free, this book about medicine offers essential guidance for anyone taking medication and is an ideal quick-reference guide for healthcare professionals and carers. It is also great for anyone wanting to know more about the drugs used in common medical practice.You''ll discover what to do if a
£9.49
McGraw-Hill Education - Europe Clinical Physiology of AcidBase and Electrolyte
Book SynopsisâœThe core of information that the clinician should possessâ -- From the PrefaceDoody's Core Titles for 2021!Like its highly acclaimed predecessors, the Fifth Edition of this classic effectively integrates the essentials of renal and electrolyte physiology with the common clinical disorders of acid-base and electrolyte balance.FEATURES:*An easy-to-read writing style that demystifies this difficult subject*Basic science coverage of water and electrolyte physiology, renal physiology, and regulation of water and electrolyte balance*Clinical chapters that quickly guide you through key points of etiology, pathophysiology, symptoms, diagnosis, and treatment of common disorders*Crystal clear figures and handy tables that summarize key information*End-of-chapter problems that test mastery of the materialNEW IN THIS EDITION:*New sections on endothelin and nitric oxide*State-of-the-art information on the properties of the cTable of ContentsPart One: Renal Physiology. Chapter 1: Introduction to Renal Function. Chapter 2: Renal Circulation and Glomerular Filtration Rate. Chapter 3: Proximal Tubule. Chapter 4: Loop of Henle and the Countercurrent Mechanism. Chapter 5: Functions of the Distal Nephron. Chapter 6: Effects of Hormones on Renal Function. Part Two: Regulation of Water and Electrolyte Balance. Chapter 7: The Total Body Water and the Plasma Sodium Concentration. Chapter 8: Regulation of the Effective Circulating Volume. Chapter 9: Regulation of Plasma Osmolality. Chapter 10: Acid-Base Physiology. Chapter 11: Regulation of Acid-Base Balance. Chapter 12: Potassium Homeostasis. Part Three: Physiologic Approach to Acid-Base and Electrolyte Disorders. Chapter 13: Meaning and Application of Urine Chemistries. Chapter 14: Hypovolemic States. Chapter 15: Clinical Use of Diuretics. Chapter 16: Edematous States. Chapter 17: Introduction to Simple and Mixed Acid-Base Disorders. Chapter 18: Metabolic Alkalosis. Chapter 19: Metabolic Acidosis. Chapter 20: Respiratory Acidosis. Chapter 21: Respiratory Alkalosis. Chapter 22: Introduction to Disorders of Osmolality. Chapter 23: Hypoosmolal States - Hyponatremia. Chapter 24: Hyperosmolal States - Hyponatremia. Chapter 25: Hyperosmolal States - Hyperglycemia Chapter 26: Introduction to Disorders of Potassium Balance. Chapter 27: Hypokalemia. Chapter 28: Hyperkalemia. Chapter 29: Answers to the Problems. Chapter 30: Summary of Equations and Formulas.
£77.39
Pharmaceutical Press Palliative Care Formulary PCF 9
Book Synopsis
£71.10
Oxford University Press Oxford Handbook of Prescribing for Nurses and
Book SynopsisThe new revised third edition of the Oxford Handbook of Prescribing for Nurses and Allied Health Professionals, provides concise, practical, and expert guidance on all aspects of non-medical prescribing. Now thoroughly updated, key advice has been organised by practice specialty, to aid learning and decision making in prescribing practice, and ensure the vital information is always at your fingertips. Using information from the authors'' years of experience as nurse practitioners and teachers, this practical handbook is packed with a wealth of recommendations, guidance, and support. Containing the practical principles nurses and other non-medical prescribers need to practice safely, effectively and cost-consciously whatever the situation, it provides evidence-based advice on a wide selection of subjects to give a complete picture of the role of the prescriber. The topics covered range from basic pharmacology, to the legal aspects and processes of prescribing practice, as well as prescribing for specific conditions and special groups, such as the older person and the very young.This new edition features the most recent legislation and changes to prescribing standards, giving nurses and non-medical prescribers access to the most up-to-date information to inform their practice. This new edition has been reorganised to focus on the most common scopes of practice, for both acute and long conditions frequently managed by NMPs, to ensure ease-of-access to essential information.Written by practising nurses and checked by subject experts and pharmacologists, the Oxford Handbook of Prescribing for Nurses and Allied Health Professionals, third edition continues to be an essential companion for all nurse and non-medical prescribers. It is ideal for students taking prescribing courses as a detailed and practical guide to practice as it covers all the competency areas, through to established practitioners who would like a handy reference to dip into when needed, as well as for other non-medical prescribers.
£28.49
Elsevier Health Sciences Brodys Human Pharmacology
Book Synopsis
£56.04
Hammersmith Health Books Blind Trust: How Parents with a Sick Child Can
Book SynopsisAn insider's look into the world of pediatric drug trials: when research outcomes can quite literally represent life or death Many parents of children with serious health problems may wonder why new medicines are initially not approved for minors and, if their condition is rare, why at the same time there is such pressure to enter any young person under 18 into drug trials. So-called 'paediatric' pharmaceutical studies have become an international multi-billion business, with many careers in academia, regulatory authorities and the pharmaceutical industry based on this work, yet much of this activity is founded on a series of flawed concepts that have led to an immeasurable waste of resources and serious, ongoing medical abuse. In this revelatory book, the former head of paediatric drug research at two major pharmaceutical companies provides a guide for parents and non-specialists interested in advancing the health of children--both individuals facing serious disease and groups of children enrolled in testing programs. Rose explains the key differences between clinically-directed and administratively-directed research, what will potentially benefit or harm children, and how laws need to change around the world so that true advances can be made.
£13.59
Open University Press Essentials of Pharmacology for Nurses 4e
Book SynopsisThis ideal starter text for student nurses in pharmacology is now into its 4th edition. It makes pharmacology less intimidating by focusing on the knowledge needed at pre-registration level in order to safely and competently practice as a newly qualified nurse.Praised for its helpful layout and jargon-free language, this updated edition introduces pharmacology in a friendly, informative way, without assuming previous knowledge or a level of confidence in numeracy. This new edition has been carefully expanded to include new chapters on cardiovascular pharmacology and chemotherapy in cancer nursing. There are more details on drugs used in chronic and long-term conditions applied to nursing competencies and standards. It incorporates the new 2018 NMC standards for nursing education and links to practice guidelines. Additional case scenarios have been added spanning all areas of practice and include adult, elderly care, child, mental health and learning disability applicationTable of ContentsCHAPTER 1Pharmacodynamics and pharmacokineticsCHAPTER 2Adverse drug reactions and interactionsCHAPTER 3Drug calculations and numeracy skillsCHAPTER 4Local anaesthetics and analgesicsCHAPTER 5AntimicrobialsCHAPTER 6Anti-inflammatory drugsCHAPTER 7Anticoagulant therapyCHAPTER 8Drugs for respiratory conditionsCHAPTER 9Drugs for diabetes mellitusCHAPTER 10Cardiovascular drugsCHAPTER 11Drugs for Parkinson’s disease and epilepsyCHAPTER 12Drugs used in mental healthCHAPTER 13Cancer chemotherapy and symptom managementCHAPTER 14Patient concordanceCHAPTER 15Legal and professional issues
£32.29
Pharmaceutical Press Pharmacy OSCEs
Book SynopsisPharmacy OSCEs is the only pharmacy-specific OSCE revision guide. This easy-to-use book covers the key competencies that will be tested during your Objective Structured Clinical Examinations whether you are still studying or in practice.Table of Contents1. Responding to symptoms and history-taking; 2. Systems-based client assessment; 3. Legal aspects of prescriptions, and record-keeping; 4. Data retrieval and interpretation; 5. Clinical prescription management problems; 6. General health advice; 7. Counselling (medication and devices); 8. Problems involving calculations.
£23.75
Cambridge University Press Practical Psychopharmacology
Book SynopsisAn accessible book for clinicians at all levels of training and experience who prescribe psychiatric medications and wish to better understand the rationale and empirical evidence base behind choosing treatments optimally tailored to the needs of individual patients.Trade Review'Psychopharmacology textbooks are typically either scholarly, endlessly long and inaccessible to clinicians, or clinician-friendly but with inadequate documentation for readers who want more detailed information. Somehow, Goldberg and Stahl's Practical Psychopharmacology combines the best of these two styles. It is astonishingly comprehensive with many Tables citing every relevant study while simultaneously providing the deep practical wisdom and experience of the two authors, both of whom are world class clinician-scholars. Practical Psychopharmacology also provides a sophisticated yet accessible review of the biological underpinnings of both psychopathology and medication effects. It does not just inform; it teaches the reader how to think about medications. This book will set the standard in our field for the foreseeable future.' Michael Gitlin, Distinguished Professor of Clinical Psychiatry, Director, Adult Division of Psychiatry, Director, Mood Disorders Clinic, Geffen School of Medicine at UCLA'The translation of clinical research findings into practice is fraught. The methodology of many trials is imperfect, complex, and opaque and hard to generalise to real world patients. Many critical questions are poorly answered by the extant evidence. The basic neuroscience is extraordinarily complex. This book is a Rosetta stone for translating this evidence into practice in providing a critical bridge for practising clinicians in distilling and interpreting the evidence into clear and coherent pragmatic management and prescribing recommendations. Written by two of the world's premier authorities, it is infused with a rare synergy of clinical wisdom and neuroscience expertise and is an essential resource for any practising prescriber of psychotropic agents.' Michael Berk, NHMRC Senior Principal Research Fellow; Alfred Deakin Professor of Psychiatry, School of Medicine, Deakin University and Barwon Health; Director, IMPACT, the Institute for Mental and Physical Health and Clinical Translation'Drs. Goldberg and Stahl have reminded us that they are scientific artisans by creating a pragmatic, patient-centered set of guiding principles in clinical psychopharmacology. The emergence of newer psychopharmacologic treatments and expansion of indications for previously available agents has provided hope for identifying therapeutic avenues for patients to improve their general wellbeing, but also can feel daunting, overwhelming, and a source of entropy. Consequently, it is not uncommon for clinicians at point of care to be genuinely perplexed as to which treatments and capabilities are 'promising rather than prime-time'. The authors have deftly synthesized the scientific literature and have produced a book that is comprehensive, concise, and an invaluable source of decision support at the point of care for multidisciplinary practitioners who provide care to persons with mental disorders.' Roger S. McIntyre, Professor of Psychiatry and Pharmacology and Head, Mood Disorders Psychopharmacology Unit, University of Toronto, CanadaTable of ContentsPart I. General Principles: 1. Core concepts of good psychopharmacology; 2. Targets of treatment: categories versus dimensions of psychopathology; 3. Interpreting and using the literature: integrating evidence-based trials with real-world practice; 4. Placebo and nocebo effects; 5. Tailoring the fit: moderators and mediators of treatment outcome; 6. Complex regimens and rationale-based combination drug therapies; 7. Laboratory values and psychiatric symptoms: what to measure, what not to measure, and what to do with the results; 8. Pharmacogenetics: when relevant, when not; 9. Cross-tapering and the logistics of drug discontinuation; 10. Managing major adverse drug effects: when to avoid, switch, or treat through; 11. Novel drug therapeutics: nutraceuticals, steroids, probiotics, and other dietary supplements; 12. Human diversity and considerations in special populations; Part II. Targets of Pharmacotherapy: 13. Disordered mood and affect; 14. Disorders of impulsivity, compulsivity, and aggression; 15. Psychosis; 16. Deficit states and negative symptoms; 17. Anxiety; 18. Addiction and the reward pathway; 19. Trauma and posttraumatic stress disorder; 20. Personality disorders; 21. Cognition; 22. Putting it all together; References; Index.
£55.09
Elsevier Australia Herbs and Natural Supplements Volume 2
Book Synopsis
£44.57
Taylor & Francis Ltd Inhaled Delivery Systems for the Treatment of
Book SynopsisInhaled therapies form the cornerstone for treatment of patients with asthma and COPD. Evolving technology has resulted in availability of a wide range of devices for delivery of inhaled drugs. The four different delivery systems -- pressurized metered-dose inhalers, slow mist inhalers, dry powder inhalers, and nebulizers -- are unique in design and require distinct inhalational instructions for correct use. This book provides current information about inhalation devices, including their advantages and disadvantages, with guidance for optimal techniques of use. The book emphasizes appropriate selection of inhalation devices based on patient and health care professional factors as well as device attributes that allow selection of the right medication in the right inhalation device at the right time for the right patient.Key Features: Addresses the objective of precision medicine the right medication in the right inhaler device at the right time. Inputs by internationaTable of ContentsForeword. About the Editors. List of Contributors. Introduction. Principles of Inhaled Therapy. Goals of Pharmacotherapy for Asthma and COPD. Pressurized Metered-Dose Inhalers (pMDI). Spacers and Valved Holding Chambers. Slow Mist Inhalers. Dry Powder Inhalers. Digital Inhalers for the Management of Obstructive Lung Diseases. Nebulizers. Inhalation Therapy in Infants and Children. Selection of Inhaler Delivery System for Adult Outpatients. Inhalation Therapy in the Intensive Care Unit. Inhaled Therapy for Other Respiratory Diseases: Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis. Inhaled Therapy for Other Respiratory Diseases: Pulmonary Hypertension. Regulatory Considerations Related to Inhaled. Delivery Systems. Index.
£48.99
Pearson Education Pharmacology for Nurses A Pathophysiologic Approach Global Edition
Book SynopsisAbout our authors Michael Patrick Adams, PhD, is an accomplished educator, author and national speaker. The National Institute for Staff and Organizational Development in Austin, Texas, named him a Master Teacher. He has published two other textbooks with Pearson Publishing: Core Concepts in Pharmacology and Pharmacology: Connections to Nursing Practice. Dr. Adams obtained his master's degree in pharmacology from Michigan State University and his doctorate in education from the University of South Florida. He was on the faculty of Lansing Community College and St. Petersburg College and served as Dean of Health Professions at Pasco-Hernando State College for 15 years. He is currently Adjunct Professor of Biological Sciences at Hillsborough Community College. Dr. Adams volunteers at the St. Petersburg Free Clinic, which provides medical care to adults with no health insurance. Leland Norman (Norm) Holland, Jr., PhD, over 25 years ago, started out like many scientists, planning for a career in basic science research. He was quickly drawn to the field of teaching in higher medical education, where he has spent most of his career. Among the areas where he has been particularly effective are preparatory programs in nursing, medicine, dentistry, pharmacy and allied health. Dr. Holland is both a professor and supporter in nursing education nationwide. He brings to the profession a depth of knowledge in biology, chemistry and medically related subjects, such as microbiology, biological chemistry and pharmacology. Dr. Holland's doctoral degree is in medical pharmacology. He is very much dedicated to the success of students and their preparation for careers in health care. He continues to motivate students in the lifelong pursuit of learning. Shanti Ellen Chang, DNP, MSHI, FNP-BC, Assistant Professor, is a Family Nurse Practitioner and Adult-Gerontology Nurse Practitioner, Doctor of Nursing Practice Program Director at George Mason University in Fairfax, Virginia. She started working in healthcare 15 years ago and now leads an interprofessional telehealth clinic with students from various health disciplines. Dr. Chang is passionate about serving vulnerable populations and wants to guide and prepare the future healthcare workforce to brainstorm and implement evidence-based, creative solutions to improve health across the world. Carol Quam Urban, PhD, RN, Associate Professor, is the Director for Administrative Controls & Screening Operations for Employee Health and Well-Being at George Mason University in Fairfax, Virginia. Prior to this position, she taught nursing pharmacology in the School of Nursing for over 25 years, and served as the Director of the School. She considers pharmacology to be a course that truly integrates nursing knowledge, skills and interdisciplinary teamwork. She has co-authored the Pearson textbook Pharmacology: Connections to Nursing Practice with Dr. Adams and has worked on previous editions of Pharmacology for Nurses: A Pathophysiologic Approach.
£73.14
Chelsea Green Publishing Co The LDN Book: How a Little-Known Generic Drug —
Book SynopsisCould a little-known drug really revolutionize treatment for autoimmune diseases, cancer, depression, and more? “[LDN] raises hopes of reversing memory loss in old age.”—the Guardian Over 30,000 copies sold! Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers, and even autism, chronic fatigue, and depression, find relief. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects. So why has it languished in relative medical obscurity? The LDN Book explains: The drug’s origins Its primary mechanism The latest research from practicing physicians and pharmacists Compiled by Linda Elsegood of The LDN Research Trust—the world’s largest LDN charity organization with over 19,000 members worldwide—the book features ten chapters contributed by medical professionals on LDN’s efficacy and two patient-friendly appendices. The LDN Book is a comprehensive resource for doctors, pharmacists, and patients who want to learn more about how LDN is helping people now, and a clarion call for further research that could help millions more.Trade Review“I first came across LDN several years ago when a medical colleague said I should look into its positive effects in patients with MS, Crohn’s disease, and other autoimmune disorders. I was so impressed with what I read that I helped submit a petition to the UK government to ask for funding for further research into this inexpensive drug. But, as with so many petitions, no progress was made. I hope The LDN Book—which presents up-to-date findings that again confirm the efficacy of this safe, cheap, generic drug in helping to control many chronic, disabling conditions—is read by those in the Department of Health and by all doctors caring for patients with autoimmune disease. In the UK, LDN has been stranded in limbo; maybe now the time has come for it to be accepted as a recognized therapy that could, at least, be tried on those suffering such long-term diseases of the immune system.”--Dr. Chris Steele, MBE, general practitioner; medical presenter on ITV’s This Morning“As a practicing physician who has used LDN as a cornerstone therapy for over fifteen years, I can say without equivocation that LDN is the most important and successful medicine I have ever used. I often joke that if not for LDN I couldn’t pay my mortgage; I’ve had so many new patients referred to me by someone whose life has improved dramatically through the use of LDN. And despite my knowledge and experience with LDN, I’ve learned a great deal from The LDN Book—aspects of its basic science I hadn’t known, new uses, and how its uses can inform us about the causes of various diseases. This is a wonderful book for any patient with an autoimmune disease, cancer, depression, or a host of other conditions and is a must-read for any physician whose goal is to help their patients.”--Dr. Thomas Cowan, author of The Fourfold Path to Healing and coauthor of The Nourishing Traditions Book of Baby & Child Care“Low Dose Naltrexone (LDN) was discovered by my husband and partner, Dr. Bernard Bihari. Incredibly informative and superbly written by various members of the medical profession sharing their experiences using this extraordinary drug, The LDN Book honors his legacy in helping patients suffering from autoimmune and other diseases to regain their health and their lives.”--Jacqueline Young
£19.12
Pharmaceutical Press Introducing Palliative Care
Book SynopsisIntroducing Palliative Care is the ideal introductory text for training students in medicine and qualified healthcare professionals in the area of palliative care. The sixth edition has been fully revised in line with current practice and the latest edition of the Palliative Care Formulary (PCF7).
£23.75
Pharmaceutical Press Drugs in Use
Book SynopsisDrugs in Use: Case Studies for Pharmacists and Prescribers helps you to bridge the gap between theoretical knowledge about medicines and the practical application to your patients. The sixth edition of this popular text has been extensively revised to ensure that a primary care focus is included whenever possible, in order to reflect the fact that drug management of chronic conditions increasingly takes place in primary care, and that this is an expanding role for pharmacists working in GP surgeries. There are new chapters on atrial fibrillation, chronic asthma, general surgery, sepsis, deprescribing and supporting adherence.
£42.75
Lippincott Williams and Wilkins Introduction to the Pharmaceutical Sciences: An
Book SynopsisThis unique textbook provides an introductory, yet comprehensive overview of the pharmaceutical sciences. It is the first text of its kind to pursue an interdisciplinary approach. Readers are introduced to basic concepts related to the specific disciplines in the pharmaceutical sciences, including pharmacology, pharmaceutics, pharmacokinetics, and medicinal chemistry. In an easy-to-read writing style, the book provides readers with up-to-date information on pharmacogenomics and includes comprehensive coverage of industrial drug development and regulatory approval processes. Each chapter includes critical-thinking exercises, as well as numerous figures, tables, and graphs. Many chapters contain review questions, practice problems, and cases. More than 160 illustrations complement the text.
£71.25
Pharmaceutical Press Introduction to Pharmaceutical Calculations
Book SynopsisIntroduction to Pharmaceutical Calculations is an essential study aid for pharmacy students. The book contains worked examples and sample questions and answers.Table of Contents1 Introduction; 2 Rational Numbers; 3 Systems of Units; 4 Concentrations; 5 Dilutions; 6 Formulations; 7 Calculation of Doses; 8 Doses in Children; 9 Density, Displacement Volumes and Displacement Values; 10 Calculations Involving Molecular Weights; 11 Parenteral Solutions and Isotonicity; 12 Accuracy of Measurement; 13 Calculations Involving Information Retrieval.
£31.35
John Wiley and Sons Ltd Molecular Pharmacology
Book SynopsisProvides an introduction to the rapidly expanding field of molecular pharmacology. Adopting a drug target-based, rather than the traditional organ/system based approach, this book reflects the advances and research trend towards molecular based drug design, derived from a detailed understanding of chemical responses in the body.Trade Review“Overall, it could be the basis of an excellent course for junior pharmacologists in basic science research who need a greater focus on the mechanisms of drug action rather than an encyclopedic survey of clinical drug use.” (Doody’s, 26 July 2013)Table of ContentsPreface ix Abbreviations x 1 Introduction to Drug Targets and Molecular Pharmacology 1 1.1 Introduction to molecular pharmacology 1 1.2 Scope of this textbook 2 1.3 The nature of drug targets 3 1.4 Future drug targets 7 1.5 Molecular pharmacology and drug discovery 11 References 12 2 Molecular Cloning of Drug Targets 13 2.1 Introduction to molecular cloning – from DNA to drug discovery 13 2.2 ‘Traditional’ pharmacology 14 2.3 The relevance of recombinant DNA technology to pharmacology/drug discovery 14 2.4 The ‘cloning’ of drug targets 15 2.5 What information can DNA cloning provide? 20 2.6 Comparing the pharmacologic profile of the ‘cloned’ and the ‘native’ drug target 23 2.7 Reverse pharmacology illustrated on orphan GPCRs 24 2.8 Summary 27 References 27 3 G Protein-coupled Receptors 31 3.1 Introduction to G protein-coupled receptors 31 3.2 Heterotrimeric G-proteins 36 3.3 Signal transduction pathways 40 3.4 Desensitisation and down-regulation of GPCR signalling 44 3.5 Constitutive GPCR activity 45 3.6 Promiscuous G-protein coupling 47 3.7 Agonist-directed signalling 48 3.8 Allosteric modulators of GPCR function 49 3.9 Pharmacological chaperones for GPCRs 50 3.10 GPCR dimerisation 51 3.11 GPCR splice variants 63 3.12 Summary 67 References 67 Useful Web sites 70 4 Ion Channels 71 4.1 Introduction 71 4.2 Voltage-gated ion channels 73 4.3 Other types of voltage-gated ion channels 89 4.4 Ligand-gated ion channels 109 4.5 Summary 125 References 125 5 Transporter Proteins 129 5.1 Introduction 129 5.2 Classification 129 5.3 Structural analysis of transporters 132 5.4 Transporter families of pharmacological interest 133 5.5 Transporters and cellular homeostasis 167 5.6 Summary 169 References 169 6 Cystic Fibrosis: Alternative Approaches to the Treatment of a Genetic Disease 175 6.1 Introduction 175 6.2 Cystic fibrosis transmembrane conductance regulator 179 6.3 Mutations in CFTR 183 6.4 Why is cystic fibrosis so common? 184 6.5 Animal models of Cystic fibrosis 186 6.6 Pharmacotherapy 186 6.7 Gene therapy 191 6.8 Conclusion 195 References 196 7 Pharmacogenomics 201 7.1 Types of genetic variation in the human genome 201 7.2 Thiopurine S-methyltransferase and K+ channel polymorphisms 202 7.3 Polymorphisms affecting drug metabolism 204 7.4 Methods for detecting genetic polymorphisms 209 7.5 Genetic variation in drug transporters 211 7.6 Genetic variation in G protein coupled receptors 215 7.7 Summary 225 References 225 Useful Web sites 226 8 Transcription Factors and Gene Expression 227 8.1 Control of gene expression 227 8.2 Transcription factors 229 8.3 CREB 233 8.4 Nuclear receptors 238 8.5 Peroxisome proliferator-activated receptors 240 8.6 Growth factors 247 8.7 Alternative splicing 247 8.8 RNA editing 251 8.9 The importance of non-coding RNAs in gene expression 257 8.10 Summary 270 References 271 9 Cellular Calcium 277 9.1 Introduction 277 9.2 Measurement of calcium 278 9.3 The exocrine pancreas 289 9.4 Calcium signalling in pancreatic acinar cells 292 9.5 Nuclear calcium signalling 303 9.6 Conclusions 310 References 311 10 Genetic Engineering of Mice 315 10.1 Introduction to genetic engineering 315 10.2 Genomics and the accumulation of sequence data 315 10.3 The mouse as a model organism 318 10.4 Techniques for genetic engineering 319 10.5 Examples of genetically-engineered mice 332 10.6 Summary 334 References 334 11 Signalling Complexes: Protein-protein Interactions and Lipid Rafts 339 11.1 Introduction to cell signalling complexes 339 11.2 Introduction to GPCR interacting proteins 340 11.3 Methods used to identify GPCR interacting proteins 340 11.4 Functional roles of GPCR interacting proteins 345 11.5 GPCR signalling complexes 348 11.6 GPCR and ion channel complexes 355 11.7 Ion channel signalling complexes 356 11.8 Development of pharmaceuticals that target GPCR interacting proteins 356 11.9 Development of pharmaceuticals that target protein-protein interactions 356 11.10 Lipid rafts 357 11.11 Receptor-mediated endocytosis 361 11.12 Summary 364 References 364 12 Recombinant Proteins and Immunotherapeutics 367 12.1 Introduction to immunotherapeutics 367 12.2 Historical background of immunotherapeutics 368 12.3 Basis of immunotherapeutics 368 12.4 Types of immunotherapeutics 369 12.5 Humanisation of antibody therapy 372 12.6 Immunotherapeutics in clinical practice 376 12.7 Advantages and disadvantages of immunotherapy 378 12.8 The future 379 12.9 Summary 380 References 380 Glossary 381 Index 403
£53.15
Elsevier - Health Sciences Division Applied Pharmacology for the Dental Hygienist
Book SynopsisTable of ContentsPart I: General Principles 1. Information, Sources, Regulatory Agencies, Drug Legislation, and Prescription Writing 2. Drug Action and Handling 3. Adverse Reactions Part II: Drugs Used in Dentistry 4. Autonomic Drugs 5. Nonopioid (Nonnarcotic) Analgesics 6. Opioid (Narcotic) Analgesics and Antagonists 7. Antiinfective Agents 8. Antifungal and Antiviral Agents 9. Local Anesthetics 10. General Anesthetics 11. Antianxiety Agents Part III: Drugs That May Alter Dental Treatment 12. Drugs for the Treatment of Cardiovascular Diseases 13. Drugs for the Treatment of Gastrointestinal Disorders 14. Drugs for the Treatment of Seizure Disorders 15. Drugs for the Treatment of Central Nervous System Disorders 16. Adrenocorticosteroids 17. Drugs for the Treatment of Respiratory Disorders and Allergic Rhinitis 18. Drugs for the Treatment of Diabetes Mellitus 19. Drugs for the Treatment of Other Endocrine Disorders 20. Antineoplastic Drugs Part IV: Special Situations 21. Emergency Drugs 22. Pregnancy and Breast Feeding 23. Substance Use Disorders 24. Natural/Herbal Products and Dietary Supplements 25. Oral Conditions and Their Treatment 26. Hygiene-Related Oral Disorders Appendix A: Medical Acronyms Appendix B: Medical Terminology Appendix C: What if. Appendix D: Oral Manifestations: Xerostomia and Taste Changes Appendix E: Children's Dose Calculations Glossary Drug Index Index
£61.74
Elsevier Health Sciences Pharmacy OSCEs and CompetencyBased Assessments
Book SynopsisTable of ContentsChapter 1. Introduction Chapter 2. Clinical check pre-dispensing and final check on dispensed medication Chapter 3 Responding to symptoms and counselling Chapter 4 Medication Reconciliation Chapter 5. Inter- and intra- professional assessments Chapter 6. Prescribing Skills Chapter 7. Competency-based Assessments Chapter 8. Dealing with Symptoms in the Community Pharmacy
£20.89
Pharmaceutical Press Nonprescription Medicines
Book SynopsisThis new edition of Non-prescription Medicines reviews over-the-counter (OTC) medicines currently available in the UK, in alphabetically arranged chapters on the conditions that they are licensed to treat.
£38.00
Cambridge University Press Pharmacology for Anaesthesia and Intensive Care
Book SynopsisThe fifth edition of this popular textbook continues to provide a solid foundation of pharmacological knowledge for all those working in anaesthesia and intensive care. The content has been thoroughly revised to include expanded chapters with clearer figures, ensuring readers are kept abreast of the ever-changing landscape of clinical pharmacology. Conveniently divided into four sections covering the basic principles of pharmacology, core drugs in anaesthetic practice, cardiovascular drugs, and other important drugs and complemented by new diagrams, tables and chemical formulae to facilitate learning. All four chapters on core drugs in anaesthetic practice have been updated along with others exploring applied pharmacokinetic models, antimicrobials, and drugs used in diabetes. An ideal aid to study and practice for junior and trainee anaesthetists and intensive care specialists preparing for exams. Also an invaluable resource for theatre practitioners, ICU nurses and physicians working in areas that demand a solid knowledge of pharmacology.Trade Review'This outstanding book differentiates itself from others through its effective use of figures and diagrams that enhance learning. It is comprehensive and provides sufficient detail for the use of these medications. The information is not so overwhelming as to render it forgotten after reading. The inclusion of new anticoagulants and their reversal and the update on antibiotics make this new edition necessary.' Robert R. Gaiser, Doody's Notes'… an invaluable resource for anyone, both doctor or nurse/ODP working in anaesthesia and intensive care. Its well-written explanations on the topics offer easy to understand insight which will only benefit the reader and lead to a greater depth of knowledge.' Daniel Morgan, The Journal of Perioperative Practice'A pleasant surprise for the reader will be how easily these subsections flow as the authors keep the more detailed and in-depth information accessible and interesting by associating the concepts to relevant drugs … This book is useful for trainees preparing for examinations and for experienced practitioners as a shelf reference; it is well organised so that specific topics or drugs can be individually reviewed.' Daniel Pulsipher, British Journal of AnaesthesiaTable of ContentsPreface: Foreword by Anthony Absalom; Section I. Basic Principles: 1. Drug passage across the cell membrane; 2. Absorption, distribution, metabolism and excretion; 3. Drug action; 4. Drug interaction; 5. Isomerism; 6. Pharmacokinetic modelling; 7. Applied pharmacokinetic models; 8. medicinal chemistry; Section II. Core Drugs in Anaesthetic Practice: 9. General anaesthetic agents; 10. Analgesics; 11. Local anaesthetics; 12. Muscle relaxants and reversal agents; Section III. Cardiovascular Drugs: 13. Sympathomimetics; 14. Adrenoceptor antagonists; 15. Anti-arrhythmics; 16. Vasodilators; 17. Antihypertensives; Section IV. Other Important Drugs: 18. Central nervous system; 19. Antiemetics and related drugs; 20. Drugs acting on the gut; 21. Intravenous fluids, minerals and nutrition; 22. Diuretics; 23. Antimicrobials; 24. Drugs affecting coagulation; 25. Drugs used in diabetes; 26. Corticosteroids and other hormone preparations; Index.
£53.19
Elsevier Health Sciences Drug Discovery and Development
Book SynopsisTable of ContentsSection 1 Introduction and Background 1. Development of the pharmaceutical industry 2. Nature of disease and purpose of therapy 3. Therapeutic modalities Section 2 Drug Discovery 4. Drug target identification 5. Selecting the modality and planning the project 6. High throughput screening 7. Medicinal Chemistry 8. Biopharmaceuticals and related molecules 9. Emerging modalities: nucleotide based therapy, cell based therapy, gene therapy / Novel and Advanced Process 10. Metabolism and Pharmacokinetical strategies. 11. Role of pharmacology to include pharmacology of newer modalities 12. In vitro in vivo translation 13. Vaccines Section 3 Drug Development 14. Drug development introduction 15. Drug safety 16. Pharmaceutical development 17. Clinical development 18. Clinical imaging 19. Intellectual property 20. Regulatory affairs 21. Marketing and Patient access to medicines Section 4 Facts and Figures 22. Facts and Figures; and the Future
£47.49
Chelsea Green Publishing Co The LDN Book, Volume Two: The Latest Research on
Book SynopsisA comprehensive examination of Low Dose Naltrexone – a little-known drug with big potential New drug [LDN] raises hopes of reversing memory loss in old age the Guardian A drug that is simultaneously affordable, devoid of severe side effects, and applicable to a wide range of diseases is not often found in the modern pharmaceutical landscape. But as medical professionals and researchers alike continue to discover, Low Dose Naltrexone (LDN) boasts this remarkable combination. Expanding on the information presented in The LDN Book, Volume 1 – which showcased LDN’s efficacy in treating conditions such as lupus, thyroiditis, autism spectrum disorder, and chronic fatigue – Volume 2 highlights the latest clinical trials, case studies and research on LDN. More than a dozen medical professionals explain how they are using LDN to help patients suffering from: Chronic pain Parkinson’s disease Dermatologic conditions Traumatic brain injury Lyme disease and more. Volume 1 and Volume 2 have been edited by Linda Elsegood, founder of the UK-based LDN Research Trust. Through the Trust and her work on the LDN books, Linda has connected thousands of patients, doctors and pharmacists around the world with information, articles and patient stories about LDN. The LDN Book, Volume 2 is a fantastic resource for practitioners, pharmacists and patients and a renewed call for further research on the healing potential of this beneficial drug.Trade Review“Since the first volume of The LDN Book was released, I have had the distinct privilege of learning from and collaborating with the best clinicians and researchers in the field of integrative medicine. Through these collaborations, we continue to build upon the already vast applications of this low-dose but high-power medication. I am thrilled to see so many trusted colleagues, who have also become friends, contribute to this important body of work. Thank you, again, Linda Elsegood, for bringing together a tribe of like-minded people who continue to find solutions to challenging medical issues with this simple and inexpensive intervention.”—Dr. Nasha Winters, ND, FABNO, author of The Metabolic Approach to Cancer“As a pharmacist, I often wish for a ‘miracle’ drug that would be safe, effective, and inexpensive and could help the masses take back their health. While no drug is right for everyone, I have seen LDN transform the lives of countless people with autoimmunity. For some, LDN has truly been a miracle drug. I highly recommend both volumes of The LDN Book as valuable resources for patients and clinicians alike to explore the best practices for using LDN.”—Dr. Izabella Wentz, Pharm.D., FASCP, New York Times bestselling author of Hashimoto’s Protocol“A fantastic resource. All the latest research on low dose naltrexone and its various uses in clinical practice is compiled in this easy-to-use volume—The LDN Book, Volume 2. I will definitely be keeping this book in my office for reference.”—Jill C. Carnahan, MD, ABIHM, ABoIM, IFMCP“Even if you think you know about the benefits of LDN for certain conditions through practical experience or otherwise, this book will expand your understanding and amazement. It is a remarkable finding that a drug designed for a specific condition can be applied to so many other systems at lower and lower doses. Interestingly, this has shown us that many other drugs may also have unexpected benefits at lower-than-intended doses. There are many layers of complexity that remain to be uncovered!”—Dr. Angus Dalgleish, professor of oncology, St. George’s, University of London; principal, Institute for Cancer Vaccines and Immunotherapy (ICVI)“Over the years, a wealth of clinical trials and studies on LDN have given us better information about how and why LDN actually works. Through this research, we have uncovered many new uses of LDN in medical treatment. Reviewing The LDN Book, Volume 2 and seeing how other experts prescribe LDN in their clinics has been a great treat for me. My clinic, Clinic 158, has been prescribing LDN for 12 years. We have thousands of very happy patients who have found success with the medication for a myriad of ailments, and we are still learning new information.”—Dr. Andrew McCall, director, Clinic 158“Since inflammation is a major contributor to almost all chronic disorders, LDN therapy bridges nearly every medical specialty. In The LDN Book, Volume 2, the authors provide an excellent overview of LDN’s mechanism of action, review the vast evidence base supporting clinical applications, and, most importantly, report actual cases in which LDN was instrumental in the successful treatment of patients. This book is a must-have for every clinician, and LDN should be considered in the treatment of the many disorders outlined therein.”—Sahar Swidan, Pharm.D., R.Ph., ABAAHP, FAARFM, FACA, president and CEO, Pharmacy Solutions
£19.12
Oxford University Press Oxford Handbook of Practical Drug Therapy
Book SynopsisThis Handbook mirrors the leading national guides to prescribing. The safe and effective use of medicine requires a sound knowledge of pharmacology. As readers use this practical book, they will increase their knowledge.Trade ReviewI would recommend the Oxford Handbook of Practical Drug Therapy for both use on the wards and for revision for medical school exams. . . Its in depth cover of relevant prescribing information will make it a useful resource for junior doctors as well as medical students. * Lucy Faulkner, Northwing Magazine Sheffield University Medical Students Magazine *This is a small compact and easy to utilise drug therapy manual. Overall a well set out easy to follow guide that would be useful for health professionals of all levels. * ANTS Bulletin *Table of ContentsIntroductory sections ; 1. Gastrointestinal system ; 2. Cardiovascular system ; 3. Respiratory system ; 4. Central nervous system ; 5. Infections ; 6. Endocrine system ; 7. Kidneys and the urinary tract ; 8. Malignant disease and immunosuppression ; 9. Nutrition and blood ; 10. Musculoskeletal and joints ; 11. Eye ; 12. Skin ; 13. Poisoning ; 14. Immunological products and vaccines ; 15. Relief of pain and anaesthetic drugs
£32.29
Dorling Kindersley Ltd New Guide to Medicine and Drugs
Book Synopsis
£18.99
Elsevier - Health Sciences Division Ciottones Disaster Medicine
Book SynopsisTable of ContentsPart 1: Overview of Disaster Management Section 1: Introduction Section 2: Domestic and International Resources Section 3: Pre-Event Topics Section 4: Event-Response Topics Section 5: Mechanical Operations in Disasters Section 6: Post-Event Topics Section 7: Topics Unique to Terrorist Events and High-Threat Disaster Response Section 8: Operational Medicine Part 2: Management of Specific Event Types Section 9: Natural Disasters Section 10: Nuclear/Radiation Events Section 11: Chemical Events Section 12: Biological Events: Introduction Section 12: Biological Events, Part 1: Bacterial Agents Section 12: Biological Events, Part 2: Viral Agents Section 12: Biological Agents, Part 3, Toxins Section 12: Biological Agents, Part 4: Other Biological Agents Section 13: Events Resulting in Blast Injuries Section 14: Events Resulting in Burn Injuries Section 15: Events Resulting in Ballistic Injuries Section 16: Events Resulting in Structural Collapse/Crashing/Crushing Section 17: Other Events/Combination Events
£116.09
Elsevier - Health Sciences Division Essentials of Pharmacology and Therapeutics for
Book SynopsisTable of Contents1) Pharmacodynamics 2) Pharmacokinetics and Pharmacogenetics 3) Pharmacotherapeutics 4) Introduction to autonomic nervous system (ANS) 5) Autonomic Drugs (adrenergic and cholinergic) 6) General anesthetics and sedative-hypnotic drugs 7) Local Anesthetics 8) Anti-infective agents (antibiotics, antifungal, antiviral) 9) Analgesics and Acute Pain Management 10) Autacoids 11) Anticonvulsants and antiparkinsonian drugs 12) Bone sparing drugs 13) Cardiac and vascular drugs 14) Drugs action on respiratory system 15) Endocrine drugs (Parathyroid, Adrenals, Insulin, Sex Steroids) 16) Immunological drugs 17) Antineoplastics 18) Toxicology and adverse drug interactions 19) Drugs specific to dentistry 20) Emergency drugs 21) Prescription Writing
£38.99
Taylor & Francis Drugs in Sport
Book SynopsisDrugs in Sport is the most comprehensive and accurate text on the emotive, complex and critical subject of performance enhancement and doping within sport. Thoroughly updated in light of the latest World Anti-Doping Code and taking into account the latest regulations, procedures and landmark cases, this 8th edition explores the science behind drug use in sport, as well as its ethical, social, political and administrative context. Introducing an increased focus on athletes with specific needs and on corrupt doping practices, the book covers key topics including:- an evaluation of the prevalence of doping in sport; - the latest doping control regulations stipulated by the World Anti-Doping Agency (WADA); - the science and side effects of each major class of drug used in sport;- cutting-edge issues such as drug use by transgender athletes; - medical and anti-doping considerations for athletes with an impairment;- governance and Table of ContentsSection 1: The Context and Regulation of Drug Use in Sport 1. Drugs and their Use in Sport2. The Evolution of Doping and Anti-doping in Sport3. Prevalence of Doping in Sport4. Regulation of Anti-doping in Sport – International and National Operational Frameworks5. Doping Control in Sport6. The Role of Athlete Support Personnel in Drug Use in Sport7. Medical and Pharmacy Services for International GamesSection 2: Substances and Methods Used and Misused in Sport8. Anabolic Agents9. Peptide Hormones, Growth Factors, Related Substances and Mimetics10. Beta-2 Agonists11. Hormone and Metabolic Modulators12. Diuretics and Masking Agents13. Manipulation of Blood and Blood Components14. Chemical and Physical Manipulation15. The potential for gene and cell doping in sport16. Stimulants17. Caffeine18. Cannabinoids19. Glucocorticoids20. Narcotics21. Non-narcotic analgesics and Non-steroidal Anti-inflammatory Drugs22. Beta Blockers23. Alcohol24. Sports Nutrition, Supplements and Herbal PreparationsSection 3: Evolving Issues Concerning Drug Use in Sport 25. Drug Use in Society and the Potential Impact on the Anti-doping Movement26: Inadvertent Use of Prohibited Substances in Sport27. Hormonal Treatments for Transgender Athletes and Athletes with aDifference of Sex Development 28. Medical and Anti-doping Consideration for Athletes with Disability 29. Governance and Corruption in Sport with Respect to Doping
£51.29
CRC Press Handbook of Systemic Drug Treatment in
Book SynopsisThe Handbook of Systemic Drug Treatment in Dermatology helps prescribers and patients make rational decisions about drug treatment while considering known risks and potential unwanted effects. Written for dermatologists, family practitioners, pharmacists and specialist nurses, this completely revised and updated third edition of a bestseller provides an accessible and concise aid to prescribing and monitoring systemic dermatologic therapy. For each drug or drug class, the book lists its classification, mode of action, formulations, dosages, suggested regimens, contraindications, important drug interactions, adverse effects, patient information, and more. This third edition includes new classes of drugs as well as information on updated guidelines for prescribing and monitoring established drugs.FROM REVIEWS OF PREVIOUS EDITIONSThis updated edition includes new arrivalsâ Quite simply, it is indispensable! I have it with me in every clinic and oftTable of Contents1. Acitretin. 2. Acne Antibiotics. 3. Alitretinoin 4. Antiandrogens. 5. Antibiotics Commonly Used for Skin Infections. 6. Antifungals. 7. Antimalarials. 8. Antivirals. 9. Apremilast. 10. Azathioprine. 11. Azole Antihelminths. 12. Bexarotene. 13. Ciclosporin. 14. Colchicine. 15. Corticosteroids. 16. Cyclophosphamide. 17. Dapsone. 18. Dimethyl Fumarate. 19. Interleukin 4/13 inhibitors. 20. Interleukin (IL)-12/23 and IL-23 Inhibitors. 21. Interleukin-17. antagonists. 22. Isotretinoin. 23. Ivermectin. 24. Intravenous Immunoglobulin. 25. Janus Kinase (JAK) Inhibitors. 26. Malignant Melanoma Drug Treatments. 27. Methotrexate. 28. Mycophenolate Mofetil. 29. Omalizumab. 30. Potassium Iodide. 31. Propranolol. 32. Psoralens. 33. Rituximab. 34. Sulfapyridine & Sulfamethoxy- pyridazine. 35. Thalidomide. 36. Tumour Necrosis Factor Antagonists. 37. Vismodegib. 38. Systemic Treatment in Children. 39. Kidney Disease. 40. Systemic Therapy & Liver Disease. 41. Systematic Therapy in Older People.
£65.54
Elsevier Science Advances in Extraction and Applications of
Book SynopsisTable of Contents1. Pharmaceutical prospects of plant-based bioactive molecules 2. Utilization of plants and their different portions for the extraction of bioactive phytochemicals and their high throughput screening techniques 3. Conventional approaches for the extraction of bioactive compounds for pharmaceutical applications 4. Advancement in bioactive compound extraction from natural products for pharmaceutical applications 5. Neoteric solvents for extraction of bioactive phytochemicals 6. Application and effectiveness of computational methods in improving the production of bioactive phytochemicals 7. Advances in encapsulation strategies for bioactive phytochemicals 8. Applications of herb-derived bioactive phytochemicals 9. Pharmacological and therapeutic aspects of various medicinal plants 10. Applications of plant-derived metal nanoparticles in pharmaceuticals 11. Patents on naturally derived pharmaceuticals
£101.25
Elsevier Health Sciences Crash Course Pharmacology
Book Synopsis
£31.34
Elsevier Science Drug Discovery Stories Volume 2
£146.69
Elsevier Health Sciences Rang Dales Pharmacology Flash Cards
Book Synopsis
£30.39
